Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-10-29 4:30 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | INTEGRATED CORE STRATEGIES (US) LLC | 2,778,525 5.200% | 1,047,636 (+60.53%) | View |
| 2024-07-16 6:06 pm Purchase | 13D | MILESTONE PHARMACEUTICALS INC MIST | Alta Fundamental Advisers LLC | 2,658,589 4.990% | 987,300 (+59.07%) | View |
| 2024-02-14 8:56 pm Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | Venrock Healthcare Capital Partners III L.P. | 925,048 2.800% | -1,283,764 (-58.12%) | View |
| 2024-02-14 07:10 am Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | RTW INVESTMENTS LP | 3,354,825 9.990% | -960,277 (-22.25%) | View |
| 2024-02-09 7:41 pm Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | GOLDMAN SACHS GROUP INC GS | 1,359,540 4.100% | -1,390,845 (-50.57%) | View |
| 2024-01-29 4:42 pm Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | INTEGRATED CORE STRATEGIES (US) LLC | 1,730,889 5.200% | -464,140 (-21.15%) | View |
| 2024-01-24 2:27 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | BlackRock Inc. BLK | 3,270,749 9.800% | 1,542,920 (+89.30%) | View |
| 2023-11-09 4:43 pm Purchase | 13D | MILESTONE PHARMACEUTICALS INC MIST | Alta Fundamental Advisers LLC | 1,671,289 5.000% | 1,671,289 (New Position) | View |
| 2023-02-14 4:45 pm Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | ORBIMED CAPITAL LLC | 0 0.000% | -2,583,821 (Position Closed) | View |
| 2023-02-14 4:45 pm Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,246,503 (Position Closed) | View |
| 2023-02-14 4:07 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | Venrock Healthcare Capital Partners III L.P. | 2,208,812 6.400% | 136,803 (+6.60%) | View |
| 2023-02-14 1:13 pm Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | Boxer Capital LLC | 698,861 2.000% | -1,540,000 (-68.78%) | View |
| 2023-02-14 11:03 am Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | Ikarian Capital LLC | 460,416 1.300% | -1,289,627 (-73.69%) | View |
| 2023-02-13 09:06 am Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | BlackRock Inc. BLK | 1,727,829 5.000% | 1,727,829 (New Position) | View |
| 2023-01-19 09:19 am Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | GOLDMAN SACHS GROUP INC GS | 2,750,385 8.000% | 2,750,385 (New Position) | View |
| 2023-01-18 4:40 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | INTEGRATED CORE STRATEGIES (US) LLC | 2,195,029 6.400% | 290,732 (+15.27%) | View |
| 2022-10-31 4:40 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | INTEGRATED CORE STRATEGIES (US) LLC | 1,904,297 6.300% | 1,904,297 (New Position) | View |
| 2022-10-24 12:46 pm Sale | 13D | MILESTONE PHARMACEUTICALS INC MIST | Novo Holdings A/S | 1,378,538 4.600% | -719,175 (-34.28%) | View |
| 2022-09-26 4:04 pm Purchase | 13D | MILESTONE PHARMACEUTICALS INC MIST | Novo Holdings A/S | 2,097,713 7.000% | 16,828 (+0.81%) | View |
| 2022-09-19 9:14 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | Venrock Healthcare Capital Partners III L.P. | 2,072,009 6.900% | 2,072,009 (New Position) | View |